EXHIBIT 99.2

FRIDAY FEBRUARY 9, 5:00 PM EASTERN TIME
PRESS RELEASE

      BIOPOOL INTERNATIONAL/XTRANA ANNOUNCES RESIGNATION OF JOHN H. WHEELER

     VENTURA,  Calif.  -(BUSINESS  WIRE)-  Feb. 9, 2001-  Biopool  International
Inc./Xtrana  (OTCBB:BIPL - NEWS) today  announced the  resignation  of its chief
executive officer, John H. Wheeler.

     Wheeler resigned because of philosophical  differences with the board after
the merger of the two companies. Timothy J. Dahltorp, chief financial officer of
the company,  has been appointed interim chief operating officer.  The board has
also created an  executive  management  committee  consisting  of board  members
Michael Bick, Ph.D., and James H. Chamberlain. The company also announced that a
search is underway for a successor president and CEO of the company.

     Michael Bick,  chairman of the board,  stated: "We are grateful to Jack for
his  contributions  to the founding and building of the Xtrana  business,  a key
component of our future growth strategy,  and his vision will be missed. We wish
Jack well in his future projects."

     James H.  Chamberlain  was the  founder  of  Biosource  International  Inc.
(Nasdaq:BIOI  - NEWS),  a  California-based  company  dedicated to the research,
development,   manufacturing,  and  marketing  of  biomedical  products  to  the
diagnostic and research markets.  Prior to founding  Biosource,  Chamberlain was
the  manager  of  Business  Development  for Amgen Inc.  Chamberlain  received a
bachelor  of  science  degree  in  biology  and  chemistry  from  West  Virginia
University  in  1969  and  completed  an MBA  Executive  Program  at  Pepperdine
University in 1981.

     Founded in 1987, Biopool International develops,  manufactures, and markets
a full range of test kits to assess and diagnose disorders of blood coagulation,
thrombotic  risk  factors,  fibrinolysis,  platelet  function  and the  vascular
system.  Effective  with the  company's  merger with  Xtrana,  the company  also
develops  nucleic  acid-based  tests  for use in drug  discovery,  detection  of
environmental and food contaminants,  forensics and identity testing,  human and
animal diseases,  genetic  predisposition to disease and other applications.  To
learn more about  Biopool  International  and  Xtrana,  visit their Web sites at
WWW.BIOPOOL.COM and www.xtrana.com.

CONTACT:
     Biopool International Inc./Xtrana
     Timothy Dahltorp, 303/474-2133
     Carol Hill, 805/654-0643


                                       7